Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Frontiers in Genetics|May 25, 2023
Identification of the lncRNA-miRNA‒mRNA regulatory network for middle cerebral artery occlusion-induced ischemic strokeGuixin Shi, Dong He, Hua Xiao, et al.Frontiers in Pharmacology|March 6, 2023
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancerMan Wang, Lijie Zhu, Xiaoxu Yang, et al.European Journal of Pharmacology|August 20, 2025
Post-marketing safety profile of Ertugliflozin: Insights from a real-world pharmacovigilance analysis based on the FAERS databaseHuqiang Dong, Qian Guo, Mengyuan Cai, et al.Frontiers in Pharmacology|April 10, 2023
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancerXin Zhang, Xuemei Wang, Lijian Hou, et al.Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Dihydroartemisinin Promotes N1 Polarization of Tumor-Associated Neutrophils and Enhances Their Anti-Tumor Activity via Hub Gene ModulationWenjia Guo, Yu'e Liu, Wencong Ma, et al.IUBMB Life|February 3, 2026
ADAM15 Is a Potential Biomarker for Pan-Cancer Prognosis and Immunotherapy: Validation in HCC and COADWenjia Guo, Yu'e Liu, Wencong Ma, et al.Journal of Zhejiang University. Science. B|August 8, 2023
FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of FOXO1/miR-506/ETS1/FOXO1Chao Chen, Yu'e Liu, Hongxiang Wang, et al.Frontiers in Pharmacology|May 22, 2023
Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapyJing-Fen Shi, Yu'e Liu, Yan Wang, et al.Cell Death & Disease|August 14, 2023
The diversified role of mitochondria in ferroptosis in cancerYu'e Liu, Shiping Lu, Lei-Lei Wu, et al.Cells|August 26, 2022
An Epigenetic Role of Mitochondria in CancerYu'e Liu, Chao Chen, Xinye Wang, et al.Pageof 6